Nitrite treatment downregulates vascular MMP-2 activity and inhibits vascular remodeling in hypertension independently of its antihypertensive effects

Free Radic Biol Med. 2019 Jan:130:234-243. doi: 10.1016/j.freeradbiomed.2018.11.002. Epub 2018 Nov 3.

Abstract

Hypertension is associated with cardiovascular remodeling. Given that impaired redox state activates matrix metalloproteinase (MMP)- 2 and promotes vascular remodeling, we hypothesized that nitrite treatment at a non-antihypertensive dose exerts antioxidant effects and attenuates both MMP-2 activation and vascular remodeling of hypertension. We examined the effects of oral sodium nitrite at antihypertensive (15 mg/kg) or non-antihypertensive (1 mg/kg) daily dose in hypertensive rats (two kidney, one clip; 2K1C model). Sham-operated and 2K1C hypertensive rats received vehicle or nitrite by gavage for four weeks. Systolic blood pressure decreased only in hypertensive rats treated with nitrite 15 mg/Kg/day. Both low and high nitrite doses decreased 2K1C-induced vascular remodeling assessed by measuring aortic cross-sectional area, media/lumen ratio, and number of vascular smooth muscle cells/aortic length. Both low and high nitrite doses decreased 2K1C-induced vascular oxidative stress assessed in situ with the fluorescent dye DHE and with the lucigenin chemiluminescence assay. Vascular MMP-2 expression and activity were assessed by gel zymography, Western blot, and in situ zymography increased with hypertension. While MMP-2 levels did not change in response to both doses of nitrite, both doses completely prevented hypertension-induced increases in vascular MMP activity. Moreover, incubation of aortas from hypertensive rats with nitrite at 1-20 μmol/L reduced gelatinolytic activity by 20-30%. This effect was fully inhibited by the xanthine oxidase (XOR) inhibitor febuxostat, suggesting XOR-mediated generation of nitric oxide (NO) from nitrite as a mechanism explaining the responses to nitrite. In vitro incubation of aortic extracts with nitrite 20 μmol/L did not affect MMP-2 activity. These results show that nitrite reverses the vascular structural alterations of hypertension, independently of anti-hypertensive effects. This response is mediated, at least in part, by XOR and is attributable to antioxidant effects of nitrite blunting vascular MMP-2 activation. Our findings suggest nitrite therapy to reverse structural alterations of hypertension.

Keywords: Hypertension; MMP-2; Nitrite; Oxidative stress; Vascular remodeling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antihypertensive Agents / pharmacology
  • Antioxidants
  • Aorta / drug effects
  • Aorta / pathology
  • Blood Pressure / drug effects
  • Disease Models, Animal
  • Febuxostat / pharmacology
  • Gene Expression Regulation / drug effects
  • Humans
  • Hypertension, Renovascular / drug therapy*
  • Hypertension, Renovascular / genetics
  • Hypertension, Renovascular / pathology
  • Matrix Metalloproteinase 2 / genetics*
  • Muscle, Smooth, Vascular / drug effects
  • Nitric Oxide / metabolism
  • Nitrites / pharmacology*
  • Oxidative Stress / drug effects*
  • Rats
  • Reactive Oxygen Species
  • Vascular Remodeling / drug effects
  • Xanthine Oxidase / antagonists & inhibitors
  • Xanthine Oxidase / genetics

Substances

  • Antihypertensive Agents
  • Antioxidants
  • Nitrites
  • Reactive Oxygen Species
  • Febuxostat
  • Nitric Oxide
  • Xanthine Oxidase
  • Matrix Metalloproteinase 2